Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q2 2022 Results - Earnings Call Transcript
Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Biora Therapeutics, Inc's (BIOR) CEO Adi Mohanty on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Remark Holdings, Inc.'s (MARK) CEO Kai-Shing Tao on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Viridian Therapeutics, Inc. (VRDN) CEO Jonathan Violin on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Inhibikase Therapeutics, Inc. (IKT) CEO Milton Werner on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Rockwell Medical, Inc. (RMTI) CEO Mark Strobeck on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Trevi Therapeutics, Inc. (TRVI) CEO Jennifer Good on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha